Cunningham Steven E 4

4 · Enova International, Inc. · Filed Apr 30, 2026

AI-generated summary of this filing

Updated Apr 30, 2026

Enova (ENVA) CEO Steven Cunningham Sells Shares, Exercises Options

What Happened

Steven E. Cunningham, Chief Executive Officer of Enova International (ENVA), exercised stock options to acquire 3,696 shares (exercise price $31.98; cash paid $118,198) and sold shares in open-market transactions the same day.
On 2026-04-28 Cunningham sold 3,696 shares acquired via option exercise at $175.50 for $648,648, and separately sold 4,156 existing shares at $175.50 for $729,378. Total reported gross sale proceeds were $1,378,026. A related derivative entry for 3,696 shares was reported with $0 proceeds (see footnotes).

Key Details

Transaction date: April 28, 2026. Filing date: April 30, 2026 (filed within the SEC two-business-day Form 4 requirement).
Option exercise: 3,696 shares exercised at $31.98 per share (total exercise cost $118,198).
Sales: 3,696 shares sold at $175.50 ($648,648) and 4,156 shares sold at $175.50 ($729,378).
Total shares sold: 7,852; total gross sale proceeds: $1,378,026.
Post-transaction holdings: Not provided in the summary data; see the full Form 4 for Cunningham’s total ownership after these transactions.
Footnotes: The filing notes a limited stock appreciation right (SAR) and employee stock option were granted in tandem; exercising one causes the other to expire. An SAR-related line shows $0 proceeds in this filing (no cash paid), consistent with the tandem grant mechanics. The options vested in roughly equal thirds on Feb 2, 2023; Feb 3, 2024; and Feb 3, 2025.

Context

This appears to be a cashless-style transaction for the exercised options: Cunningham paid the exercise price to acquire 3,696 shares and immediately sold those shares in the open market the same day.
Sales by executives can be routine (liquidity, tax obligations, diversification) and do not by themselves indicate a change in company outlook. No 10b5-1 plan or other prearranged plan was disclosed in the provided data.

Form 4

Period: 2026-04-28

DirectorChief Executive Officer

Transactions

Sale
Common stock, par value $0.00001 per share
2026-04-28$175.50/sh−4,156$729,378→ 122,945 total
Exercise/Conversion
Common stock, par value $0.00001 per share
2026-04-28$31.98/sh+3,696$118,198→ 126,641 total
Sale
Common stock, par value $0.00001 per share
2026-04-28$175.50/sh−3,696$648,648→ 122,945 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy) with limited SAR
[F1][F2][F3]
2026-04-28−3,696→ 7,391 total
Exercise: $31.98Exp: 2028-08-03→ Common stock; par value $0.00001 per share (3,696 underlying)

Footnotes (3)

[F1]The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
[F2]The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
[F3]The options vested in substantially equal one-third increments on each of the following dates: February 2, 2023, February 3, 2024 and February 3, 2025.

Signature

/s/ Sean Rahilly, as attorney in fact|2026-04-30

1 file